Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Testing for celiac disease without endoscopy

21.04.2006


Professor Markku Mäki and Ilma Korponay-Szabo MD, PhD, of the University of Tampere in Finland have developed a reliable new method which makes it possible to diagnose celiac disease quickly and easily. The research results were translated into a commercial product by a Finnish company. The test returns a result in 10-15 minutes.



A pinprick of blood is taken from the fingertip to test for tissue transglutaminase and endomysial antibodies. An increased level of antibodies correlates well with the incidence of celiac disease. The test can also be used to monitor the patient’s diet.

The Tekes’ research into Business Programme -programme helped commercialize the research results. Ani Biotech Oy and its sister company Ani Labsystems Ltd. Oy have licensed the patent for the new invention from the research team and Finn-Medi Oy for worldwide exploitation.


The research results were translated into a commercial product by Ani Biotech. The quickest test kit contains all the equipment that is necessary to carry out the test. The test returns a result in 10-15 minutes and has been proven to be very reliable and user-friendly in all the comparative studies carried out in various countries.

Diagnosis of celiac disease is traditionally based on clinical symptoms and laboratory testing. Conclusive verification involves a biopsy of the mucous membrane of the small intestine by endoscopy to find the typical tissue changes in the sample.

Celiac disease is a condition where gluten from wheat, rye and barley damages the mucous membrane of the small intestine. This results in a number of typical symptoms in the digestive tract and often also many other atypical symptoms. The condition usually develops in childhood and is permanent unless diagnosed and treated. Treatment usually simply consists of a gluten-free diet. About 20,000 people have been diagnosed with celiac disease in Finland, but research suggests that the actual number of people with celiac disease could be as high as 50,000.

Eeva Ahola | alfa
Further information:
http://www.tekes.fi
http://www.tekes.fi/eng/news/uutis_tiedot.asp?id=5078

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>